 |
| Prime Minister Jeong Sye-gyun is all speaking at the 3rd High-ranking Party Political Council held at the National Assembly in Yeouido, Seoul on the morning of the 19th. 2021.3.19/News1 © News1 Reporter Park Se-yeon |
Prime Minister Jeong Sye-gyun said on the controversy on the safety of the AstraZeneca (AZ) novel coronavirus infection (Corona 19) vaccine on the 19th, “The government is currently proceeding in Korea, considering the results of verification by international organizations and adverse reaction cases confirmed so far “We believe there is no reason to stop vaccination against the AstraZeneca vaccine.”
On the morning of that day, Prime Minister Jung quickly convened the Vaccination Specialized Committee at the Korea Centers for Disease Control and Prevention, and thoroughly reviewed the recent evaluation data from WHO (World Health Organization) and EMA (European Medicines Agency) and cases of adverse reactions in Korea with experts to make a clear position. Clean up “and gave an urgent order.
WHO and EMA have each announced the results of discussions such as the expert committee on the point that’AstraZeneca vaccination and blood clots are not related’. In an official statement, WHO recommended that countries continue to immunize △Thrombosis is a common disease regardless of vaccination, and the benefits of AZ vaccine outweigh the risks.
The EMA also held a safety committee and concluded that the AZ vaccine was not associated with an increased overall risk of blood clots.
Even though there is no reason to stop AZ vaccine, Prime Minister Chung said, “Considering the need to continue expanding AstraZeneca vaccination, the public may have any doubts or anxiety about the safety of the AstraZeneca vaccine. No,” he stressed.
Accordingly, the Agency for Disease Control instructed them to quickly convene a vaccination expert committee and clear their positions. In addition, he ordered the Ministry of Food and Drug Safety to conduct a professional and scientific evaluation of the possibility of causing blood clots of the AstraZeneca vaccine, and to disclose the results transparently.”